Latest News in the pharma Industry

Market News

Positive results for Alkermes’ Phase III study spell good news for major depressive disorder space

Positive results for Alkermes’ Phase III study spell good news for major depressive disorder space

8 Nov 2016

GlobalData anticipates ALKS-5461 will enter the US market in early 2018.

Read more 
Mylan and Biocon announce FDA submission for proposed biosimilar trastuzumab

Mylan and Biocon announce FDA submission for proposed biosimilar trastuzumab

8 Nov 2016

Potential to be first submission of a proposed biosimilar trastuzumab in the US.

Read more 
AdAlta licenses Alzheimer's disease-specific shark antibodies to Crossbeta Biosciences

AdAlta licenses Alzheimer's disease-specific shark antibodies to Crossbeta Biosciences

8 Nov 2016

These shark antibodies are considered to have immediate and highly disease-specific potential for the diagnosis and treatment of Alzheimer’s disease.

Read more 
Seward announces merger and restructuring plans to establish FermionX Ltd

Seward announces merger and restructuring plans to establish FermionX Ltd

7 Nov 2016

Merger with sister company, C-Tech Electronics Ltd, to form a new vertically integrated manufacturing company.

Read more 
SMC ‘yes’ to first immunotherapy combination for skin cancer patients

SMC ‘yes’ to first immunotherapy combination for skin cancer patients

7 Nov 2016

Allows adult patients with advanced melanoma to receive first-line treatment with the potentially life-extending combination therapy of Opdivo (nivolumab) and Yervoy (ipilimumab) on the NHS in Scotland.

Read more 
Merck invests €250 million in production value chain in China

Merck invests €250 million in production value chain in China

6 Nov 2016

Merck is the first multinational enterprise to dedicate a large-scale green-field investment (€170 million) to the production of pharmaceuticals on China’s Essential Drug List.

Read more 
Atriva Therapeutics received Notice of Allowance from USPTO

Atriva Therapeutics received Notice of Allowance from USPTO

6 Nov 2016

Patent will cover a method of treating a subject having a viral infection caused by an influenza virus with neuraminidase inhibitors in combination with MEK inhibitors.

Read more 
Breakthrough immunotherapy for blood cancer becomes available to UK patients

Breakthrough immunotherapy for blood cancer becomes available to UK patients

6 Nov 2016

First early access scheme for breakthrough immunotherapy in blood cancer.

Read more 
CMS establishes unique J-code for Bendeka Injection

CMS establishes unique J-code for Bendeka Injection

3 Nov 2016

Provides access for patients and streamlined reimbursement.

Read more 
Endo begins shipment of generic Seroquel XR

Endo begins shipment of generic Seroquel XR

3 Nov 2016

Four dosage strengths of quetiapine fumarate extended release tablets being distributed.

Read more 
Key success factors to consider when implementing a global serialisation strategy

Key success factors to consider when implementing a global serialisation strategy

3 Nov 2016

TraceLink to present on global serialisation strategies at Pharmaceutical Serialisation & Traceability 2016.

Read more 
Recipharm invests in its Italian API facility

Recipharm invests in its Italian API facility

2 Nov 2016

As well as increasing output, the company is also investing in new technologies, including flow chemistry, chromatography and hydrogenation capabilities.

Read more